Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis

S Siafis, O Çıray, H Wu, J Schneider-Thoma, I Bighelli… - Molecular autism, 2022 - Springer
Background There is still no approved medication for the core symptoms of autism spectrum
disorder (ASD). This network meta-analysis investigated pharmacological and dietary …

The neuropathology of autism: A systematic review of post-mortem studies of autism and related disorders

R Fetit, RF Hillary, DJ Price, SM Lawrie - Neuroscience & Biobehavioral …, 2021 - Elsevier
Post-mortem studies allow for the direct investigation of brain tissue in those with autism and
related disorders. Several review articles have focused on aspects of post-mortem …

Serotonin transporter availability in adults with autism—a positron emission tomography study

M Andersson, Ä Tangen, L Farde, S Bölte… - Molecular …, 2021 - nature.com
Impairments in social interaction and communication, in combination with restricted,
repetitive behaviors and interests, define the neurodevelopmental diagnosis of autism …

Evaluating the potential use of serotonergic psychedelics in autism spectrum disorder

A Markopoulos, A Inserra, D De Gregorio… - Frontiers in …, 2022 - frontiersin.org
Recent clinical and preclinical evidence points towards empathogenic and prosocial effects
elicited by psychedelic compounds, notably the serotonin 5-HT2A agonists lysergic acid …

Pathophysiological studies of monoaminergic neurotransmission systems in valproic acid-induced model of autism spectrum disorder

HY Kuo, FC Liu - Biomedicines, 2022 - mdpi.com
Autism spectrum disorder (ASD) is a neurodevelopmental disorder with complex etiology.
The core syndromes of ASD are deficits in social communication and self-restricted interests …

Increased dopamine type 2 gene expression in the dorsal striatum in individuals with autism spectrum disorder suggests alterations in indirect pathway signaling and …

C Brandenburg, JJ Soghomonian, K Zhang… - Frontiers in Cellular …, 2020 - frontiersin.org
Autism spectrum disorder (ASD) is behaviorally defined and diagnosed by delayed and/or
impeded language, stereotyped repetitive behaviors, and difficulties with social interactions …

Modulation of serotonin receptors in neurodevelopmental disorders: Focus on 5-HT7 receptor

J Lee, D Avramets, B Jeon, H Choo - Molecules, 2021 - mdpi.com
Since neurodevelopmental disorders (NDDs) influence more than 3% of children worldwide,
there has been intense investigation to understand the etiology of disorders and develop …

Balancing therapeutic efficacy and safety of MDMA and novel MDXX analogues as novel treatments for autism spectrum disorder

H Kaur, S Karabulut, JW Gauld, SA Fagot… - Psychedelic …, 2023 - liebertpub.com
Autism spectrum disorder (ASD) encompasses a range of neurodevelopmental syndromes
diagnostically characterized by deficits in social communication and social interaction and …

Knowledge-based design of long-chain arylpiperazine derivatives targeting multiple serotonin receptors as potential candidates for treatment of autism spectrum …

E Lacivita, M Niso, M Mastromarino… - ACS Chemical …, 2021 - ACS Publications
Autism spectrum disorder (ASD) includes a group of neurodevelopmental disorders
characterized by core symptoms such as impaired social interaction and communication …

[HTML][HTML] Therapeutic effects of antidepressants for global improvement and subdomain symptoms of autism spectrum disorder: a systematic review and meta-analysis

SC Liang, CK Sun, HY Fan, W Chung, RF Tzang… - Journal of Psychiatry and …, 2022 - jpn.ca
Background: No established pharmacological treatment is available for the core symptoms
of autism spectrum disorder (ASD). This study aimed at investigating the efficacy of …